Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Sarcoma, Clear Cell × tebentafusp × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uveal Melanoma 3 Sarcoma, Clear Cell 1 Sarcoma 1 Melanoma 1

Interventions

tebentafusp 1 dostarlimab 1 cobimetinib 1 atezolizumab 1 Vemurafenib 1 Specimen Handling 1 Radiation Dose Hypofractionation 1 Diathermy 1 Crizotinib 1 Biopsy 1 ARQ 197 1 AMG 337 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06942442 2025-12-26

A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma

Sarcoma Alliance for Research through Collaboration

Phase 2 Recruiting

Sarcoma, Sarcoma, Clear Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡